*Fumiyoshi Morikawa1, Sayuri Matuzaki1, Mayumi Munekata1, Megumi Ootawa1, Kana Asada1, Musashi Tachibana1, Takeshi Hasukawa1, Toshiya Maruyama1, Takafumi Tezuka1, Tomonori Murayama1, Yuuta Sekinou1, Kazuki Tabata1, Sachiko Sirakawa1, Mitutaka Inomata1, Juichirou Naoe1 (1. Asahikawa Keisenkai hospital)
Session information
[JSNP/JSCNP joint meeting] Poster Session
JSNP/JSCNP joint meeting » Poster Session
臨床研究①
Fri. May 24, 2024 6:00 PM - 7:00 PM JSNP/JSCNP Poster Session Hall
Chair: Hitoshi Sakurai
*Fumihiro Tomoda1, Atsumi Nitta2, Tsutomu Tsutomu 3, Hiroko Sugimori3, Hiroko Kurosaki 3 (1. The Faculty of Health Science, Fukui Health Science University, 2. The Department of Pharmaceutical Therapy & Neuropharmacology, University of Toyama , 3. The Second Department of Internal Medicine, University of Toyama)
Ken Inada1, Yoshitaka Saito1, Kenji Baba2, Daisuke Fukui3, Yuriko Masuda4, Sachie Inoue4, *Takahiro Masuda2 (1. Department of Psychiatry, Kitasato University School of Medicine, 2. Medical Science, Sumitomo Pharma Co., Ltd., 3. Global Data Design Office, Sumitomo Pharma Co., 4. CRECON Medical Assessment Inc)
Takahiro Nemoto1,2, Miyuki Okumura3, Fumiya Sano3, *Hidenori Maruyama3 (1. Department of Neuropsychiatry, Toho University Faculty of Medicine, 2. Department of Psychiatry and Implementation Science, Toho University Faculty of Medicine, 3. Sumitomo Pharma Co., Ltd.)
*Kazushige Watabe1 (1. Tamiya hospital)
*Wataru Omori1,2, Naoto Kajitani2,3, Mami Okada-Tsuchioka2, Shuken Boku3, Minoru Takebayashi2,3 (1. Department of Psychiatry, Hiroshima University Hospital, 2. Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, 3. Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University)
Yoshiteru Takekita1, *Yuji Matsumoto2, Takahiro Masuda2, Kazumasa Yoshida3, Yosuke Koshikawa1, Masaki Kato1 (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 2. Medical Science, Sumitomo Pharma Co., Ltd., 3. Data Science, Sumitomo Pharma Co., Ltd.)